A case of squamous cell carcinoma of the head and neck producing granulocyte-colony stimulating factor with marked leukocytosis

Auris Nasus Larynx

Volumn 34, Issue 2, 2007, Pages 267-271

  Toyoda, Minoru ^a   Chikamatsu, Kazuaki ^a   Sakakura, Koichi ^a   Fukuda, Yoichiro ^a   Takahashi, Katsumasa ^a   Miyashita, Motoaki ^a   Shimamura, Kazuo ^b   Furuya, Nobuhiko ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

G CSF receptor; Granulocyte colony stimulating factor (G CSF); Leukocytosis; Malignant phenotype; Squamous cell carcinoma of the head and neck (SCCHN)

Indexed keywords

ANTIBODY; DIHYDROPYRIMIDINE DEHYDROGENASE; GLYCOPROTEIN P; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; PROTEIN P53; THYMIDYLATE SYNTHASE;

ADULT; ARTICLE; AUTOCRINE EFFECT; BLOOD LEVEL; CANCER PATIENT; CANCER RADIOTHERAPY; CASE REPORT; DISEASE SEVERITY; GROWTH REGULATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MOLECULE; PHYSICAL EXAMINATION; SERUM; SQUAMOUS CELL CARCINOMA; STAINING; TUMOR BIOPSY; TUMOR CELL; TUMOR GROWTH;

ABSCESS; BIOPSY; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; DIHYDROURACIL DEHYDROGENASE (NADP); DISEASE PROGRESSION; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEAD AND NECK NEOPLASMS; HUMANS; LEUKOCYTOSIS; MALE; MIDDLE AGED; NECK; PALLIATIVE CARE; RADIOTHERAPY DOSAGE; SUBMANDIBULAR GLAND; SUBMANDIBULAR GLAND NEOPLASMS; THYMIDYLATE SYNTHASE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34247135539     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2006.07.014     Document Type: Article

References (30)

1. MacManus M.P., McCormick D., Trimble A., and Abram W.P. Value of granulocyte colony stimulating factor in radiotherapy induced neutropenia: clinical and laboratory studies. Eur J Cancer 31 (1995) 302-307
2. Noda I., Fujieda S., Ohtsubo T., Tsuzuki H., Tanaka N., Sunaga H., et al. Granulocyte-colony-stimulating factor enhances invasive potential of human head-and-neck-carcinoma cell lines. Int J Cancer 80 (1999) 78-84
3. Sugimoto C., Fujieda S., Sunaga H., Noda I., Tanaka N., Kimura Y., et al. Granulocyte colony-stimulating factor (G-CSF)-mediated signaling regulates type IV collagenase activity in head and neck cancer cells. Int J Cancer 93 (2001) 42-46
4. Shijubo N., Inoue Y., Hirasawa M., Igarashi T., Mori M., Matsumura A., et al. Granulocyte colony-stimulating factor-producing large cell undifferentiated carcinoma of the lung. Intern Med 31 (1992) 277-280
5. Asahi Y., Kubonishi I., Imamura J., Kamioka M., Matsushita H., Furihata M., et al. Establishment of a clonal cell line producing granulocyte colony-stimulating factor and parathyroid hormone-related protein from a lung cancer patient with leukocytosis and hypercalcemia. Jpn J Cancer Res 87 (1996) 451-458
6. Ito N., Natsuda T., Kakehi Y., Takeuchi E., Takahashi T., Yoshida O., et al. Bladder cancer producing granulocyte colony-stimulating factor. N Engl J Med 323 (1990) 1709-1710
7. Obara T., Ito Y., Kodama T., Fujimoto Y., Mizoguchi H., Oshimi K., et al. A case of gastric carcinoma associated with excessive granulocytosis. Production of a colony stimulating factor by the tumor. Cancer 56 (1985) 782-788
8. Watanabe A., Wachi T., Omi H., Nishii H., Ochiai K., Tanaka T., et al. Granulocyte colony-stimulating factor-producing small-cell carcinoma of the uterine cervix: Report of a case. Diagn Cytopathol 23 (2000) 269-274
9. Kyo S., Kanaya T., Takakura M., and Inoue M. A case of cervical cancer with aggressive tumor growth: possible autocrine growth stimulation by G-CSF and IL-6. Gynecol Oncol 78 (2000) 383-387
10. Shimamura K., Fujimoto J., Hata J.-I., Akatsuka A., Ueyama Y., Watanabe T., et al. Establishment of specific monoclonal antibodies against recombinant human granulocyte colony-stimulating factor (hG-CSF) and their application for immunoperoxidase staining of paraffin-embedded sections. J Histochem Cytochem 38 (1990) 283-286
11. Robinson W.A. Granulocytosis in neoplasia. Ann N Y Acad Sci 230 (1974) 212-218
12. Matsuo K., Ishibashi Y., Kobayashi I., Ozeki S., Ohishi M., Tange T., et al. New human oral squamous carcinoma cell line and its tumorigenic subline producing granulocyte colony-stimulating factor. Jpn J Cancer Res 85 (1994) 1257-1262
13. Horii A., Shimamura K., Honjo Y., Mitani K., Miki T., Takashima S., et al. Granulocyte colony stimulating factor-producing tongue carcinoma. Head Neck 19 (1997) 351-356
14. Tsuzuki H., Fujieda S., Sunaga H., Noda I., and Saito H. Expression of granulocyte colony-stimulating factor receptor correlates with prognosis in oral and mesopharyngeal carcinoma. Cancer Res 58 (1998) 794-800
15. Ninck S., Reisser C., Dyckhoff G., Helmke B., Bauer H., and Herold-Mende C. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck. Int J Cancer 106 (2003) 34-44
16. Akatsuka A., Shimamura K., Katoh Y., Takekoshi S., Nakamura M., Nomura H., et al. Electron microscopic identification of the intracellular secretion pathway of human G-CSF in a human tumor cell line: a comparative study with a Chinese hamster ovary cell line (IA1-7) transfected with human G-CSF cDNA. Exp Hematol 19 (1991) 768-772
17. Bussolino F., Colotta F., Bocchietto E., Guglielmetti A., and Mantovani A. Recent developments in the cell biology of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: activities on endothelial cells. Int J Clin Lab Res 23 (1993) 8-12
18. Bikfalvi A., and Han Z.C. Angiogenic factors are hematopoietic growth factors and vice versa. Leukemia (Baltimore) 8 (1994) 523-529
19. Obermueller E., Vosseler S., Fusenig N.E., and Mueller M.M. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res 64 (2004) 7801-7812
20. Klangsinsirikul P., and Russell N.H. Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells. Exp Hematol 30 (2002) 495-501
21. Hung K., Hayashi R., Lafond-Walker A., Lowenstein C., Pardoll D., and Levitsky H. The central role of CD4+ T cells in the antitumor immune response. J Exp Med 188 (1998) 2357-2368
22. Toes R.E., Ossendorp F., Offringa R., and Melief C.J. CD4 T cells and their role in antitumor immune responses. J Exp Med 189 (1999) 753-756
23. Arpinati M., Green C.L., Heimfeld S., Heuser J.E., and Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95 (2000) 2484-2490
24. Klangsinsirikul P., and Russell N.H. Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells. Exp Hematol 30 (2002) 495-501
25. Obata A., Eura M., Sasaki J., Saya H., Chikamatsu K., Tada M., et al. Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx. Int J Cancer 89 (2000) 187-193
26. Bandoh N., Hayashi T., Kishibe K., Takahara M., Imada M., Nonaka S., et al. Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma. Cancer 94 (2002) 1968-1980
27. Gottesman M.M., Pastan I., and Ambudkar S.V. P-glycoprotein and multidrug resistance. Curr Opin Genet Dev 6 (1996) 610-617
28. Fardel O., Lecureur V., and Guillouzo A. The P-glycoprotein multidrug transporter. Gen Pharmacol 27 (1996) 1283-1291
29. Eliason J.F., and Megyeri A. Potential for predicting toxicity and response of fluoropyrimidines in patients. Curr Drug Targets 5 (2004) 383-388
30. Omura K. Clinical implications of dihydropyrimidine dehydrogenase (DPD) activity in 5-FU-based chemotherapy: mutations in the DPD gene, and DPD inhibitory fluoropyrimidines. Int J Clin Oncol 8 (2003) 132-138